Brief: Impel Pharmaceuticals Appointments Michael W. Kalb As CFO
10/05/2023 13:51
May 10 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS ANNOUNCES APPOINTMENT OF MICHAEL W.
KALB
AS CHIEF FINANCIAL OFFICER
* IMPEL PHARMACEUTICALS INC - APPOINTMENT OF MICHAEL W. KALB
AS
CHIEF FINANCIAL OFFICER, EFFECTIVE MAY 10
Source text for Eikon: ID:nGNX2QJXPj
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq